Phosphodiesterase 5 Inhibitor [EPC]

108801 reported adverse events

Drugs of this class: TADALAFIL AVANAFIL FINASTERIDE AND TADALAFIL SILDENAFIL VARDENAFIL HYDROCHLORIDE

These side effects are most commonly reported by patients taking drugs of the Phosphodiesterase 5 Inhibitor [EPC] class:

#	Side effect	Count
0	DYSPNOEA	13718
1	HEADACHE	11198
2	DIARRHOEA	8066
3	DEATH	7190
4	NAUSEA	7031
5	DRUG INEFFECTIVE	6321
6	FATIGUE	6096
7	DIZZINESS	5547
8	PNEUMONIA	5045
9	MALAISE	4273

See all common reactions for Phosphodiesterase 5 Inhibitor [EPC]

Drugs of the Phosphodiesterase 5 Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	INFUSION SITE DISCHARGE	274	0.4059
1	CATHETER SITE PRURITUS	287	0.3786
2	CATHETER MANAGEMENT	323	0.3773
3	CATHETER SITE DISCHARGE	270	0.3154
4	PULMONARY ARTERIAL HYPERTENSION	3797	0.2989
5	CATHETER SITE ERYTHEMA	481	0.2873
6	PULMONARY ARTERIAL PRESSURE INCREASED	403	0.2840
7	INFUSION SITE INFECTION	453	0.2810
8	LIBIDO DISORDER	309	0.2791
9	RIGHT VENTRICULAR FAILURE	1625	0.2594

See all enriched reactions for Phosphodiesterase 5 Inhibitor [EPC]